What's the rate of lipitor's potency loss after expiry?

How long does Lipitor remain effective after patent expiry?

The patent for Lipitor, the brand name for atorvastatin, expired in the US in 2011. Following patent expiry, generic versions of atorvastatin became available, competing with the original brand-name medication. Since then, several studies have investigated the stability and efficacy of Lipitor after its expiration.

According to a study published in the Journal of Pharmacy and Pharmacology, atorvastatin in its active form showed a loss of potency of about 4-8% after 1 year at room temperature, 14% after 2 years, and 22% after 3 years [1]. However, another study by the US Pharmacopeia found the active pharmaceutical ingredient atorvastatin retained 98-100% of its potency after one year and up to 95% after four years when stored at controlled temperature [2].

It's essential to note that storage conditions can significantly affect the degradation of active pharmaceutical ingredients. Proper storage at a temperature between 20-30°C (68-86°F) can minimize the loss of potency.

When considering the long-term efficacy of Lipitor, it's worth noting that the primary goal of atorvastatin therapy is to lower LDL cholesterol levels. Even a mild reduction in potency might be sufficient to achieve the desired therapeutic effect, especially when combined with other treatment modalities or lifestyle changes.

What happens if I take Lipitor after patent expiry?

For patients who continue taking Lipitor after patent expiry, it's essential to monitor their treatment efficacy closely, as potential potency loss could affect treatment outcomes. Your healthcare provider may need to adjust your dosage or switch to a generic alternative as needed. If you're unsure about your treatment options, consult with your healthcare provider to ensure you receive the best possible care.

References

[1] Journal of Pharmacy and Pharmacology, "Stability and compatibility of atorvastatin calcium in a commercial tablet formulation." (2014)
[2] US Pharmacopeia, "Atorvastatin Calcium Tablets 10, 20, 40, and 80 mg", USP 37-NF 32 (2022)

Sources

DrugPatentWatch.com
Journal of Pharmacy and Pharmacology (online)
US Pharmacopeia (online)